12/8
10:40 pm
ophly
Has Ono Pharmaceutical's 2025 Share Price Rally Left Limited Upside? [Yahoo! Finance]
Neutral
Report
Has Ono Pharmaceutical's 2025 Share Price Rally Left Limited Upside? [Yahoo! Finance]
12/6
09:50 am
ophly
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]
Low
Report
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]
11/17
01:13 am
ophly
Deciphera Announces the Opening of a New Office in Zug, Switzerland [Yahoo! Finance]
Low
Report
Deciphera Announces the Opening of a New Office in Zug, Switzerland [Yahoo! Finance]
10/18
07:21 am
ophly
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025 [Yahoo! Finance]
Low
Report
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025 [Yahoo! Finance]
10/9
08:31 am
ophly
Ono Announces Encouraging Efficacy Signals of ONO-2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy [Yahoo! Finance]
Low
Report
Ono Announces Encouraging Efficacy Signals of ONO-2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy [Yahoo! Finance]
10/9
08:31 am
ophly
Ono Announces ONO-4578 (EP4 antagonist) in Combination with Opdivo and Chemotherapy Met the Primary Endpoint in a Phase 2 Clinical Trial in Patients with Certain Gastric Cancer [Yahoo! Finance]
Low
Report
Ono Announces ONO-4578 (EP4 antagonist) in Combination with Opdivo and Chemotherapy Met the Primary Endpoint in a Phase 2 Clinical Trial in Patients with Certain Gastric Cancer [Yahoo! Finance]
10/6
03:00 am
ophly
Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment [Yahoo! Finance]
Neutral
Report
Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment [Yahoo! Finance]